Praxis Precision Medicines (PRAX) had the highest return between October 9, 2025 and November 30, 2025 by a mid-cap US stock, returning 263.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Praxis Precision Medicines (PRAX) | 10/9/2025 - 11/30/2025 | 263.95% |
Terns Pharmaceuticals (TERN) | 10/9/2025 - 11/30/2025 | 239.08% |
Olema Pharmaceuticals (OLMA) | 10/9/2025 - 11/30/2025 | 164.18% |
Cogent Biosciences (COGT) | 10/9/2025 - 11/30/2025 | 158.15% |
PACS (PACS) | 10/9/2025 - 11/30/2025 | 155.43% |
Nuvation Bio (NUVB) | 10/9/2025 - 11/30/2025 | 115.86% |
Cidara Therapeutics (CDTX) | 10/9/2025 - 11/30/2025 | 115.57% |
Celcuity LLC (CELC) | 10/9/2025 - 11/30/2025 | 105.92% |
Central Puerto (CEPU) | 10/9/2025 - 11/30/2025 | 102.81% |
BBVA Banco Frances SA ADR (BBAR) | 10/9/2025 - 11/30/2025 | 93.41% |
Banco Macro SA B ADR (BMA) | 10/9/2025 - 11/30/2025 | 89.58% |
Grupo Financiero Galicia SA ADR (GGAL) | 10/9/2025 - 11/30/2025 | 85.47% |
Telecom Argentina SA ADR (TEO) | 10/9/2025 - 11/30/2025 | 81.77% |
Belite Bio Inc ADR (BLTE) | 10/9/2025 - 11/30/2025 | 75.91% |
Sandisk (SNDK) | 10/9/2025 - 11/30/2025 | 75.81% |
Arcus Biosciences (RCUS) | 10/9/2025 - 11/30/2025 | 73.42% |
Establishment Labs (ESTA) | 10/9/2025 - 11/30/2025 | 72.66% |
Vicor (VICR) | 10/9/2025 - 11/30/2025 | 72.42% |
Spyre Therapeutics (SYRE) | 10/9/2025 - 11/30/2025 | 69.88% |
Edgewise Therapeutics (EWTX) | 10/9/2025 - 11/30/2025 | 69.31% |
Alphatec (ATEC) | 10/9/2025 - 11/30/2025 | 61.07% |
Zymeworks Inc Common Stock (ZYME) | 10/9/2025 - 11/30/2025 | 60.04% |
Haemonetics (HAE) | 10/9/2025 - 11/30/2025 | 59.7% |
Inspire Medical Systems (INSP) | 10/9/2025 - 11/30/2025 | 57.7% |
Kohl's (KSS) | 10/9/2025 - 11/30/2025 | 57.12% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
